Broadband-gap perovskite solar cell and full-perovskite laminated solar cell
By replacing formamidinium iodide with methylammonium bromide and guanidine bromide in perovskite solar cells, the photoluminescence yield and carrier lifetime of the perovskite thin film were adjusted, solving the open-circuit voltage loss and stability problems of wide-bandgap cells in all-perovskite tandem solar cells, and achieving efficient and stable photoelectric conversion.
Patent Information
- Application Number
- CN202411655964.X
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-11-19
- Publication Date
- 2026-05-19
AI Technical Summary
In existing all-perovskite tandem solar cells, the open-circuit voltage loss and fill factor of wide-bandgap cells limit the cell efficiency, and the stability issues of wide-bandgap cells affect the device efficiency and stability.
By replacing part of formamidinium iodide with methylammonium bromide and guanidine bromide through a multi-element A-site alloy structure in perovskite solar cells, the photoluminescence yield and carrier lifetime of the perovskite thin film are adjusted, non-radiative recombination at the interface is reduced, and the cell performance is improved.
It significantly improves the photoelectric conversion efficiency and stability of perovskite solar cells, enhances carrier lifetime, and the device still maintains more than 80% efficiency after 1000 hours of operation.
Smart Images

Figure CN122069924A_ABST
Abstract
Description
Technical Field
[0001] This invention relates to the field of solar cell technology, and more specifically, to a wide-bandgap perovskite solar cell and an all-perovskite tandem solar cell. Background Technology
[0002] Organic-inorganic hybrid perovskite solar cells, as a third-generation novel solar cell, have become a highly anticipated new material internationally due to their advantages such as tunable bandgap, low fabrication cost, and long carrier lifetime. Perovskite / perovskite tandem solar cells (also known as all-perovskite tandem solar cells), constructed by cascading wide-bandgap / narrow-bandgap perovskite sub-cells, possess the advantages of high efficiency and low fabrication cost, and are an effective way to overcome the Schottky limit of single-junction perovskite solar cells. In all-perovskite tandem solar cells, by using wide-bandgap perovskite as the top cell to absorb short-wavelength sunlight and narrow-bandgap perovskite as the bottom cell to absorb long-wavelength sunlight, the utilization rate of sunlight can be improved, thereby increasing photoelectric efficiency.
[0003] Over the past decade, research on perovskite solar cells has progressed rapidly. The photoelectric conversion efficiency of all-perovskite tandem solar cells has exceeded the highest certified efficiency of 26.1% for single-cell cells and also surpasses the efficiency of monocrystalline silicon at 27%. Currently, the main limiting factors for all-perovskite tandem solar cells are the open-circuit voltage loss in the wide-bandgap cells and the fill factor.
[0004] Another difficulty limiting the development of all-perovskite tandem solar cells is the stability of wide-bandgap cells. For an ideally matched bandgap, the bandgap of a wide-bandgap sub-cell is generally around 1.80 eV, which usually results in a high bromide content. High bromide content can lead to significant phase separation problems, which will seriously affect the device efficiency and stability.
[0005] In recent years, the introduction of different molecules into the A-site to form multi-electrode alloys has been considered an effective method to improve efficiency and stability by mitigating nonradiative recombination at the interface and promoting hole and electron transport.
[0006] Therefore, developing a perovskite material that can promote electron-hole transport and reduce interfacial nonradiative recombination losses is one of the urgent problems to be solved in this field. Summary of the Invention
[0007] The purpose of this invention is to provide a perovskite precursor solution in which methylammonium bromide and guanidine bromide are used to replace part of the formamidinium iodide, which can be used to prepare wide-bandgap perovskite solar cells and significantly improve the performance of wide-bandgap perovskite solar cells, and can also be used to prepare all-perovskite tandem solar cells.
[0008] Another object of the present invention is to provide the use of perovskite precursor solutions in the fabrication of wide-bandgap perovskite solar cells and all-perovskite tandem solar cells.
[0009] Another object of the present invention is to provide a wide-bandgap perovskite solar cell prepared using a perovskite precursor solution.
[0010] Another object of the present invention is to provide an all-perovskite tandem solar cell prepared using a perovskite precursor solution.
[0011] The above-mentioned objective of the present invention is achieved by the following solution:
[0012] A perovskite precursor solution, wherein the solutes are formamidine iodide, cesium iodide, lead bromide and lead iodide, and methylammonium bromide and guanidine bromide are used to replace formamidine iodide, wherein the total molar amount of methylammonium bromide and guanidine bromide is in a molar ratio of 1:6 to formamidine iodide.
[0013] This invention introduces a multi-component A-site alloy structure into perovskite solar cells by co-doping with methylammonium bromide and guanidine bromide. The photoluminescence yield (PLQY) of the perovskite thin film is increased from 1% to 4.375%. By reducing defects in the perovskite layer, time-resolved photoluminescence spectroscopy (TRPL) tests show that the carrier lifetime of the perovskite is significantly improved, from 129.05 ns to 890.27 ns. This indicates that the non-radiative recombination on the surface of the perovskite is suppressed, reducing the voltage loss of the device and thus significantly improving the performance of the perovskite solar cell.
[0014] Preferably, the amounts of lead bromide and lead iodide are adjusted according to the amounts of methyl ammonium bromide and guanidine bromide to ensure that the contents of iodide ions and bromide ions in the perovskite precursor solution are the same before and after the addition of methyl ammonium bromide and guanidine bromide.
[0015] Preferably, the molar ratio of methylammonium bromide to guanidine bromide is 0.02–0.08:0.02–0.08.
[0016] Preferably, the molar ratio of methylammonium bromide to guanidine bromide is 0.02:0.08, 0.05:0.05, or 0.08:0.02.
[0017] Preferably, in the perovskite precursor solution, the molar ratio of formamidine iodide, cesium iodide, lead bromide, lead iodide, methylammonium bromide, and guanidine bromide is 0.7-xy:0.3:(0.45-0.5x-0.5y):(0.55+0.5x+0.5y):x:y; where 0 < x ≤ 0.10, 0 < y ≤ 0.10, and x + y = 0.1.
[0018] Preferably, 0.02≤x≤0.08, 0.02≤y≤0.08.
[0019] Preferably, x:y is 0.02:0.08, 0.05:0.05, or 0.08:0.02.
[0020] Preferably, x = y = 0.05.
[0021] This invention also protects the use of perovskite precursor solutions in the preparation of wide-bandgap perovskite solar cells.
[0022] Preferably, the wide-bandgap perovskite solar cell has a pin structure.
[0023] Preferably, the wide-bandgap perovskite solar cell comprises, in sequence: a transparent conductive glass layer, a hole transport layer, a perovskite light-absorbing layer, an electron transport layer, and a metal electrode, wherein the perovskite light-absorbing layer is prepared from the aforementioned perovskite precursor solution.
[0024] Preferably, the solutes in the perovskite precursor solution are formamidine iodide, cesium iodide, lead bromide, and lead iodide, and methylammonium bromide and guanidine bromide are used to replace formamidine iodide, wherein the total molar amount of methylammonium bromide and guanidine bromide is in a molar ratio of 1:6 to formamidine iodide.
[0025] Preferably, the molar ratio of methylammonium bromide to guanidine bromide is 0.02–0.08:0.02–0.08.
[0026] Preferably, the molar ratio of methylammonium bromide to guanidine bromide is 0.02:0.08, 0.05:0.05, or 0.08:0.02.
[0027] Preferably, in the perovskite precursor solution, the molar ratio of formamidine iodide, cesium iodide, lead bromide, lead iodide, methylammonium bromide, and guanidine bromide is 0.7-xy:0.3:(0.45-0.5x-0.5y):(0.55+0.5x+0.5y):x:y; where 0 < x ≤ 0.10, 0 < y ≤ 0.10, and x + y = 0.1.
[0028] Preferably, 0.02≤x≤0.08, 0.02≤y≤0.08.
[0029] Preferably, x:y is 0.02:0.08, 0.05:0.05, or 0.08:0.02.
[0030] Preferably, x = y = 0.05.
[0031] Preferably, the amounts of lead bromide and lead iodide are adjusted according to the amounts of methyl ammonium bromide and guanidine bromide to ensure that the contents of iodide ions and bromide ions in the perovskite precursor solution are the same before and after the addition of methyl ammonium bromide and guanidine bromide.
[0032] Preferably, a passivation layer is provided between the perovskite light-absorbing layer and the electron transport layer.
[0033] This invention also protects a wide-bandgap perovskite solar cell, comprising, in sequence: a top electrode transparent conductive glass layer, a hole transport layer, a perovskite light-absorbing layer, an electron transport layer, and a metal back electrode, wherein the perovskite light-absorbing layer is prepared from the aforementioned perovskite precursor solution.
[0034] Preferably, the solutes in the perovskite precursor solution are formamidine iodide, cesium iodide, lead bromide, and lead iodide, and methylammonium bromide and guanidine bromide are used to replace formamidine iodide, wherein the total molar amount of methylammonium bromide and guanidine bromide is in a molar ratio of 1:6 to formamidine iodide.
[0035] Preferably, the amounts of lead bromide and lead iodide are adjusted according to the amounts of methyl ammonium bromide and guanidine bromide to ensure that the contents of iodide ions and bromide ions in the perovskite precursor solution are the same before and after the addition of methyl ammonium bromide and guanidine bromide.
[0036] Preferably, the molar ratio of methylammonium bromide to guanidine bromide is 0.02–0.08:0.02–0.08.
[0037] Preferably, the molar ratio of methylammonium bromide to guanidine bromide is 0.02:0.08, 0.05:0.05, or 0.08:0.02.
[0038] Preferably, in the perovskite precursor solution, the molar ratio of formamidine iodide, cesium iodide, lead bromide, lead iodide, methylammonium bromide, and guanidine bromide is 0.7-xy:0.3:(0.45-0.5x-0.5y):(0.55+0.5x+0.5y):x:y; where 0 < x ≤ 0.10, 0 < y ≤ 0.10, and x + y = 0.1.
[0039] Preferably, 0.02≤x≤0.08, 0.02≤y≤0.08.
[0040] Preferably, x:y is 0.02:0.08, 0.05:0.05, or 0.08:0.02.
[0041] Preferably, x = y = 0.05.
[0042] Preferably, a passivation layer is provided between the perovskite light-absorbing layer and the electron transport layer.
[0043] Preferably, the transparent conductive glass layer is indium tin oxide (ITO) or fluorine-doped indium tin oxide (FTO), etc.
[0044] Preferably, the hole transport layer is made of a p-type semiconductor material.
[0045] Preferably, the hole transport layer is poly[bis(4-phenyl)(2,4,6-trimethylphenyl)amine] (PTAA), 2,2',7,7'-tetratetra[N,N-di(4-methoxyphenyl)amino]-9,9'-spirodifluorene (Spiro-OMeTAD), poly(3,4-ethylenedioxythiophene):polystyrene sulfonate (PEDOT:PSS), 4-butyl-N,N-diphenylaniline homopolymer (Ploy-TPD), polyvinylcarbazole (PVK), or a self-assembled monolayer (2PAC). It is made of one or more p-type semiconductor materials selected from z, Me-4PACz, MeO-PACz, DC-PA ((2,7-dimethoxy-9h-carbazole-9-yl)methylphosphonic acid), DC-TMPS ((3,6-dimethoxy-9H-carbazole-9-yl)trimethoxyphenylsilane), 3-MPA (thiopropionic acid)), 2,2',7,7'-tetratetra(N,N-di-p-tolyl)amino-9,9-spirodifluorene (Spiro-TTB) or poly(3-hexylthiophene) (P3HT).
[0046] Preferably, the electron transport layer is made of an n-type semiconductor material. Specifically, the n-type semiconductor material is a fullerene (C2). 60 ) or fullerene derivatives [6,6]-phenyl-C 61 1-Methyl butyrate (PCBM).
[0047] Preferably, the metal electrode is gold, silver, copper, or aluminum.
[0048] This invention also protects the use of perovskite precursor solutions in the preparation of all-perovskite tandem solar cells.
[0049] Wide-bandgap perovskite solar cells refer to perovskite cells with a bandgap of around 1.80 eV, used to meet the current matching principle of tandem solar cells. All-perovskite tandem solar cells refer to perovskite cells where two perovskite sub-cells are connected in series via an intermediate transport layer.
[0050] Preferably, the all-perovskite tandem solar cell comprises, in sequence: a transparent conductive glass layer, a hole transport layer 1, a wide-bandgap perovskite light-absorbing layer, an electron transport layer 1, a tunneling composite layer, a narrow-bandgap perovskite layer, an electron transport layer 2, and a metal top electrode; wherein the wide-bandgap perovskite light-absorbing layer is prepared from the aforementioned perovskite precursor solution.
[0051] Preferably, the solutes in the perovskite precursor solution are formamidine iodide, cesium iodide, lead bromide, and lead iodide, and methylammonium bromide and guanidine bromide are used to replace formamidine iodide, wherein the total molar amount of methylammonium bromide and guanidine bromide is in a molar ratio of 1:6 to formamidine iodide.
[0052] Preferably, the amounts of lead bromide and lead iodide are adjusted according to the amounts of methyl ammonium bromide and guanidine bromide to ensure that the contents of iodide ions and bromide ions in the perovskite precursor solution are the same before and after the addition of methyl ammonium bromide and guanidine bromide.
[0053] Preferably, the molar ratio of methylammonium bromide to guanidine bromide is 0.02–0.08:0.02–0.08.
[0054] Preferably, the molar ratio of methylammonium bromide to guanidine bromide is 0.02:0.08, 0.05:0.05, or 0.08:0.02.
[0055] Preferably, in the perovskite precursor solution, the molar ratio of formamidine iodide, cesium iodide, lead bromide, lead iodide, methylammonium bromide, and guanidine bromide is 0.7-xy:0.3:(0.45-0.5x-0.5y):(0.55+0.5x+0.5y):x:y; where 0 < x ≤ 0.10, 0 < y ≤ 0.10, and x + y = 0.1.
[0056] Preferably, 0.02≤x≤0.08, 0.02≤y≤0.08.
[0057] Preferably, x:y is 0.02:0.08, 0.05:0.05, or 0.08:0.02.
[0058] Preferably, x = y = 0.05.
[0059] Preferably, a passivation layer is provided between the wide-bandgap perovskite light-absorbing layer and the electron transport layer 1.
[0060] Preferably, a passivation layer is provided between the narrow bandgap perovskite layer and the electron transport layer 2.
[0061] This invention also protects an all-perovskite tandem solar cell, comprising, in sequence: a transparent conductive glass layer, a hole transport layer 1, a wide-bandgap perovskite light-absorbing layer, an electron transport layer 1, a tunneling composite layer, a narrow-bandgap perovskite layer, an electron transport layer 2, and a metal electrode; wherein the wide-bandgap perovskite light-absorbing layer is prepared from the aforementioned perovskite precursor solution.
[0062] Preferably, the solutes in the perovskite precursor solution are formamidine iodide, cesium iodide, lead bromide, and lead iodide, and methylammonium bromide and guanidine bromide are used to replace formamidine iodide, wherein the total molar amount of methylammonium bromide and guanidine bromide is in a molar ratio of 1:6 to formamidine iodide.
[0063] Preferably, the amounts of lead bromide and lead iodide are adjusted according to the amounts of methyl ammonium bromide and guanidine bromide to ensure that the contents of iodide ions and bromide ions in the perovskite precursor solution are the same before and after the addition of methyl ammonium bromide and guanidine bromide.
[0064] Preferably, the molar ratio of methylammonium bromide to guanidine bromide is 0.02–0.08:0.02–0.08.
[0065] Preferably, the molar ratio of methylammonium bromide to guanidine bromide is 0.02:0.08, 0.05:0.05, or 0.08:0.02.
[0066] Preferably, in the perovskite precursor solution, the molar ratio of formamidine iodide, cesium iodide, lead bromide, lead iodide, methylammonium bromide, and guanidine bromide is 0.7-xy:0.3:(0.45-0.5x-0.5y):(0.55+0.5x+0.5y):x:y; where 0 < x ≤ 0.10, 0 < y ≤ 0.10, and x + y = 0.1.
[0067] Preferably, 0.02≤x≤0.08, 0.02≤y≤0.08.
[0068] Preferably, x:y is 0.02:0.08, 0.05:0.05, or 0.08:0.02.
[0069] Preferably, x = y = 0.05.
[0070] Preferably, a passivation layer is provided between the wide-bandgap perovskite light-absorbing layer and the electron transport layer 1.
[0071] Preferably, a passivation layer is provided between the narrow bandgap perovskite layer and the electron transport layer 2.
[0072] Preferably, the tunneling composite layer is a transparent conductive metal oxide layer or a metal layer, used to transport electrons and holes.
[0073] Preferably, the transparent conductive glass layer is indium tin oxide (ITO) or fluorine-doped indium tin oxide (FTO), etc.
[0074] Preferably, the hole transport layer is made of a p-type semiconductor material.
[0075] Preferably, the hole transport layer is poly[bis(4-phenyl)(2,4,6-trimethylphenyl)amine] (PTAA), 2,2',7,7'-tetratetra[N,N-di(4-methoxyphenyl)amino]-9,9'-spirodifluorene (Spiro-OMeTAD), poly(3,4-ethylenedioxythiophene):polystyrene sulfonate (PEDOT:PSS), 4-butyl-N,N-diphenylaniline homopolymer (Ploy-TPD), polyvinylcarbazole (PVK), or a self-assembled monolayer (2PAC). It is made of one or more p-type semiconductor materials selected from z, Me-4PACz, MeO-PACz, DC-PA ((2,7-dimethoxy-9h-carbazole-9-yl)methylphosphonic acid), DC-TMPS ((3,6-dimethoxy-9H-carbazole-9-yl)trimethoxyphenylsilane), 3-MPA (thiopropionic acid)), 2,2',7,7'-tetratetra(N,N-di-p-tolyl)amino-9,9-spirodifluorene (Spiro-TTB) or poly(3-hexylthiophene) (P3HT).
[0076] Preferably, the electron transport layer is made of an n-type semiconductor material. Specifically, the n-type semiconductor material is a fullerene (C2). 60 ) or fullerene derivatives [6,6]-phenyl-C 61 1-Methyl butyrate (PCBM).
[0077] Preferably, the metal electrode is gold, silver, copper, or aluminum.
[0078] Compared with the prior art, the present invention has the following beneficial effects:
[0079] 1) During the preparation of the perovskite layer, the band gap of the perovskite can be adjusted by co-doping with GABr and MABr, thereby improving the voltage of the device; it also reduces nonradiative recombination at the perovskite interface, increases the carrier transport lifetime, achieves higher photoelectric conversion efficiency, and improves device stability.
[0080] 2) Replacing GAI (guanidine bromide) with GABr (guanidine iodide) and MAI (methyl ammonium bromide) with MABr (methyl ammonium iodide) avoids halide ion exchange (preventing I-substituted Br- into the lattice, forming the two-dimensional perovskite phase of GA) that might affect the spatial and optical properties of the perovskite lattice, thus impacting device performance. This is because when using GABr or MABr doping, GA... + and MA + Effective doping can occur in the perovskite lattice, and GAI and MAI may lead to different results. Furthermore, the use of GABr and MABr helps to achieve highly crystalline perovskite films in experiments.
[0081] Compared with the prior art, the all-perovskite tandem solar cell of the present invention has the following advantages:
[0082] 1) It has high-efficiency performance with high voltage and high fill factor;
[0083] 2) The device exhibits good stability, maintaining an efficiency of over 80% after 1000 hours of operation, providing a direction for the further development of all-perovskite tandem solar cells. Attached Figure Description
[0084] Figure 1 This is a schematic diagram of the device structure of the wide-bandgap solar cell in Example 1.
[0085] Figure 2 Performance test results of devices prepared with different doping amounts when MABr or GABr is doped alone.
[0086] Figure 3 The ratio of MABr and GABr co-doping and the performance test results of the fabricated devices.
[0087] Figure 4 The images show the photoluminescence curves of the A-site alloy wide-bandgap perovskite and the conventional wide-bandgap perovskite thin film in Example 1.
[0088] Figure 5 The image shows time-resolved photoluminescence curves of the A-site alloy wide-bandgap perovskite and the conventional wide-bandgap perovskite thin film in Example 1.
[0089] Figure 6 The virtual current density-voltage density curves are shown for the A-site alloy wide-bandgap perovskite and conventional wide-bandgap perovskite solar cells in Example 1.
[0090] Figure 7 The external quantum efficiency curves are those of the A-site alloy wide-bandgap perovskite solar cell and the conventional wide-bandgap perovskite solar cell in Example 1.
[0091] Figure 8 The image shows the long-term operational stability curve of the wide-bandgap perovskite solar cell with alloy at site A in Example 1.
[0092] Figure 9 The diagram shows the structure of the all-perovskite tandem solar cell in Example 1, and the cross-sectional view is shown under a scanning electron microscope.
[0093] Figure 10 The current density-voltage density curves are for the all-perovskite tandem solar cell in Example 1.
[0094] Figure 11 The image shows the long-term operational stability curve of the all-perovskite tandem perovskite solar cell in Example 1. Detailed Implementation
[0095] The present invention will be further described in detail below with reference to specific embodiments. These embodiments are only used to explain the present invention and are not intended to limit the scope of the present invention. Unless otherwise specified, the experimental methods used in the following embodiments are conventional methods; the materials and reagents used are commercially available unless otherwise specified.
[0096] Example 1
[0097] A wide-bandgap perovskite solar cell is fabricated, and its device structure is as follows: Figure 1 As shown, from the light-receiving front side to the light-receiving back side, it includes: a top electrode transparent conductive glass layer, a hole transport layer, a perovskite light-absorbing layer, an electron transport layer, and a metal back electrode.
[0098] The device fabrication method includes the following steps:
[0099] S1. A hole transport layer is prepared on a cleaned ITO glass substrate. The hole transport layer can be prepared using materials commonly used in the art. In this example, it is prepared using poly(4-phenyl)(2,4,6-trimethylphenyl)amine (PTAA) with a thickness of about 30 nm.
[0100] S2. Deposit a perovskite layer as a light-absorbing layer on the prepared hole transport layer;
[0101] S3. Spin-coat a layer of piperazine monoiodine (PI) at a concentration of 1 mg / mL onto the surface of the perovskite layer;
[0102] S4. Preparation of a layer of fullerene (C) by thermal evaporation 60 As an electron transport layer, its thickness is approximately 30 nm;
[0103] S5. A layer of 2,9-dimethyl-4,7-diphenyl-1,10-o-diazaphenanthroline (BCP) with a thickness of approximately 5 nm was prepared by thermal evaporation;
[0104] S6. Finally, a 150 nm thick Ag layer was deposited by thermal evaporation as the back electrode. This yielded a wide-bandgap perovskite solar cell device.
[0105] In step S2, the perovskite layer is prepared using different perovskite precursor solutions. The perovskite precursor solution is prepared by mixing formamidine iodide (FAI), cesium iodide (CsI), lead bromide (PbBr2), and lead iodide (PbI2) in a molar ratio of 0.7:0.3:0.45:0.55 (denoted as precursor solution S, where the concentration of perovskite is 1.2 mol / L; all perovskite precursor solutions below use the same concentration). The deposited perovskite layer is denoted as FA. 0.7 Cs0.3 Pb(I 0.7 Br 0.3 )3 (abbreviated as FACs), with a thickness of 400nm, the device prepared by it is denoted as CK1, and the thin film prepared by it is denoted as TF1.
[0106] The perovskite precursor solution was prepared by mixing formamidine iodide (FAI), cesium iodide (CsI), lead bromide (PbBr2), lead iodide (PbI2), and guanidine bromide (GABr) in a molar ratio of 0.7-x:0.3:(0.45-0.5x):(0.55+0.5x):x. The deposited perovskite layer was denoted as FA. 0.7-x Cs 0.3 GA x Pb(I 0.7 Br 0.3 )3 (0<x≤0.20, abbreviated as FACsGA), with a thickness of 400nm, the device prepared by this method is denoted as T1, and the thin film prepared by this method is denoted as TF2.
[0107] Referring to the preparation of device T1, the guanidine bromide (GABr) in the perovskite precursor solution was replaced with an equal amount of guanidine iodide (GAI), and the prepared device was denoted as P1.
[0108] The perovskite precursor solution was prepared by mixing formamidine iodide (FAI), cesium iodide (CsI), lead bromide (PbBr2), lead iodide (PbI2), and methylammonium bromide (MABr) in a molar ratio of 0.7-y:0.3:(0.45-0.5y):(0.55+0.5y):y. The deposited perovskite layer is denoted as FA. 0.7-y Cs 0.3 MA y Pb(I 0.7 Br 0.3 )3 (0<y≤0.20, abbreviated as FACsMA), with a thickness of 400nm, the device prepared by this method is denoted as T2, and the thin film prepared by this method is denoted as TF3.
[0109] Referring to the preparation of device T2, the methylammonium bromide (MABr) in the perovskite precursor solution was replaced with an equal amount of methyl iodine (MAI), and the prepared device was denoted as P2.
[0110] The perovskite precursor solution was prepared by mixing formamidine iodide (FAI), cesium iodide (CsI), lead bromide (PbBr2), lead iodide (PbI2), guanidine bromide (GABr), and methylammonium bromide (MABr) in a molar ratio of 0.7-xy:0.3:(0.45-0.5x-0.5y):(0.55+0.5x+0.5y):x:y. The deposited perovskite layer is denoted as FA. 0.7-x-y Cs 0.3 MAy GA x Pb(I 0.7 Br 0.3 )3 (0<x≤0.10,0<y≤0.10,abbreviated as FACsMAGA), with a thickness of 400nm, the device prepared by this method is denoted as T3, and the thin film prepared is TF4.
[0111] Referring to the preparation of device T3, the guanidine bromide (GABr) and methyl ammonium bromide (MABr) in the perovskite precursor solution were replaced with equal amounts of guanidine iodide (GAI) and methyl iodide (MAI), respectively. The prepared device is denoted as P3.
[0112] Devices T1, T2, and T3 are prepared by partially replacing formamidine iodide (FAI) with guanidine bromide (GABr) and / or methylammonium bromide (MABr) in the precursor solution S. At the same time, to ensure that the iodine and bromine content in the precursor solution remains unchanged, the ratio of lead bromide (PbBr2) and lead iodide (PbI2) is adjusted accordingly.
[0113] Devices P1, P2, and P3 are prepared by partially replacing formamidine iodide (FAI) with guanidine iodide (GAI) and / or methylamine iodide (MAI) in the precursor solution S. At the same time, to ensure that the iodine and bromine contents in the precursor solution remain unchanged, the ratio of lead bromide (PbBr2) and lead iodide (PbI2) is adjusted accordingly.
[0114] Performance testing method: The device was tested in an N2 glove box using an AM 1.5G simulator (Wavabs SINUS-70AAA solar simulator). The simulator's power was calibrated to 100mW cm⁻¹ from a silicon reference cell. -2 A KG5 filter was used to calibrate the silicon cells to ensure spectral correction within 1.00 ± 0.01. A Keithley 2400 source meter was used at a scan rate of 0.1 V / s. -1 With a voltage step size of 0.02V and a delay time of 50ms, the JV curve was obtained through 75 reverse scans (from 1.40V to -0.1V) followed by a forward scan (from -0.10V to 1.40V), with an effective area of 0.06cm². 2 The diameter is determined by the metal aperture at the front of the device.
[0115] 1.1 To investigate the effect of the amount of guanidine bromide (GABr) doping in device T1 on device performance.
[0116] Different devices T1 were prepared by adjusting x to 0.02, 0.05, 0.08, 0.1, and 0.2. Their performance was tested according to the above method, and the results are shown in Table 1.
[0117] Table 1. Effects of different GABr doping amounts on device performance
[0118] <![CDATA[V oc (V)]]> <![CDATA[J sc (mA / cm 2 )]]> FF (%) PCE (%) CK1 <![CDATA[FA 0.7 Cs 0.3 Pb(I 0.7 Br 0.3 )3]]> 1.22 18.35 77.86 17.50 T1-1 <![CDATA[FA 0.68 Cs 0.3 GA 0.02 Pb(I 0.7 Br 0.3 )3]]> 1.26 18.26 79.16 18.19 T1-2 <![CDATA[FA 0.65 Cs 0.3 GA 0.05 Pb(I 0.7 Br 0.3 )3]]> 1.26 18.00 80.52 18.29 T1-3 <![CDATA[FA 0.62 Cs 0.3 GA 0.08 Pb(I 0.7 Br 0.3 )3]]> 1.26 18.00 80.78 18.37 T1-4 <![CDATA[FA 0.6 Cs 0.3 GA 0.1 Pb(I 0.7 Br 0.3 )3]]> 1.27 18.26 78.32 18.19 T1-5 <![CDATA[FA 0.5 Cs 0.3 GA 0.2 Pb(I 0.7 Br 0.3 )3]]> 1.25 17.60 75.21 16.60
[0119] 1.2 Investigate the effect of the amount of methylammonium bromide (MABr) incorporated into device T2 on device performance.
[0120] Different devices T2 were prepared by adjusting the y value to 0.02, 0.05, 0.08, 0.1, and 0.2. Their performance was tested according to the above method, and the results are shown in Table 2.
[0121] Table 2. Effects of different MABr doping amounts on device performance
[0122] <![CDATA[V oc (V)]]> <![CDATA[J sc (mA / cm 2 )]]> FF (%) PCE (%) CK1 <![CDATA[FA 0.7 Cs 0.3 Pb(I 0.7 Br 0.3 )3]]> 1.22 18.35 77.86 17.50 T2-1 <![CDATA[FA 0.68 Cs 0.3 MA 0.02 Pb(I 0.7 Br 0.3 )3]]> 1.26 19.54 77.09 18.93 T2-2 <![CDATA[FA 0.65 Cs 0.3 MA 0.05 Pb(I 0.7 Br 0.3 )3]]> 1.26 18.99 79.29 18.94 T2-3 <![CDATA[FA 0.62 Cs 0.3 MA 0.08 Pb(I 0.7 Br 0.3 )3]]> 1.26 19.23 79.42 19.23 T2-4 <![CDATA[FA 0.6 Cs 0.3 MA 0.1 Pb(I 0.7 Br 0.3 )3]]> 1.25 19.55 78.55 19.22 T2-5 <![CDATA[FA 0.5 Cs 0.3 MA 0.2 Pb(I 0.7 Br 0.3 )3]]> 1.26 19.17 78.41 18.95
[0123] The test results of device performance when GABr or MABr is doped alone, with different doping amounts, are as follows: Figure 2 As shown.
[0124] (a) Graph showing the variation in MABr doping content in the perovskite precursor solution. (b) Graph showing the variation in GABr doping content in the perovskite precursor solution. (c) Current density-voltage density curves of devices fabricated with different MABr doping levels. Tests were conducted at room temperature under full sunlight illumination (AM1.5G, 100mW / cm²). 2 (d) The current density-voltage density curves of the fabricated devices were obtained with different GABr doping levels. The tests were conducted at room temperature under full sunlight illumination (AM1.5G, 100mW / cm²). 2 )conduct.
[0125] 1.3 Investigate the effect of the amount of guanidine iodide (GAI) doping in device P1 on device performance.
[0126] The device performance was tested using the method described above, and the test results are shown in Table 3.
[0127] Table 3. Effects of different GAI doping amounts on device performance
[0128]
[0129]
[0130] 1.4 Investigate the effect of the amount of methyl iodide (MAI) incorporated into device P2 on device performance.
[0131] The device performance was tested using the method described above, and the test results are shown in Table 4.
[0132] Table 4. Effects of different MAI doping amounts on device performance
[0133] <![CDATA[V oc (V)]]> <![CDATA[J sc (mA / cm 2 )]]> FF (%) PCE (%) CK1 <![CDATA[FA 0.7 Cs 0.3 Pb(I 0.7 Br 0.3 )3]]> 1.22 18.35 77.86 17.50 P2-1 <![CDATA[FA 0.68 Cs 0.3 MA 0.02 Pb(I 0.7 Br 0.3 )3]]> 1.22 17.77 78.90 17.14 P2-2 <![CDATA[FA 0.65 Cs 0.3 MA 0.05 Pb(I 0.7 Br 0.3 )3]]> 1.22 17.90 79.28 17.22 P2-3 <![CDATA[FA 0.62 Cs 0.3 MA 0.08 Pb(I 0.7 Br 0.3 )3]]> 1.22 17.90 79.89 17.31 P2-4 <![CDATA[FA 0.6 Cs 0.3 MA 0.1 Pb(I 0.7 Br 0.3 )3]]> 1.23 18.36 79.16 17.92 P2-5 <![CDATA[FA 0.5 Cs 0.3 MA 0.2 Pb(I 0.7 Br 0.3 )3]]> 1.24 18.02 78.16 17.39
[0134] 1.5 Investigate the effect of different doping amounts on device performance when guanidine bromide (GABr) and methyl ammonium bromide (MABr) are co-doped in device T3.
[0135] The device performance was tested using the method described above, and the test results are shown in Table 5.
[0136] Table 5. Effects of MABr and GABr co-doping on device performance
[0137] <![CDATA[V oc (V)]]> <![CDATA[J sc (mA / cm 2 )]]> FF (%) PCE (%) CK1 <![CDATA[FA 0.7 Cs 0.3 Pb(I 0.7 Br 0.3 )3]]> 1.22 18.35 77.86 17.50 T2-4 <![CDATA[FA 0.6 Cs 0.3 MA 0.1 Pb(I 0.7 Br 0.3 )3]]> 1.25 19.55 78.55 19.22 T3-2 <![CDATA[FA 0.6 Cs 0.3 MA 0.08 GA 0.02 Pb(I 0.7 Br 0.3 )3]]> 1.26 19.30 80.98 19.70 T3-3 <![CDATA[FA 0.6 Cs 0.3 MA 0.05 GA 0.05 Pb(I 0.7 Br 0.3 )3]]> 1.33 19.31 84.13 21.57 T3-4 <![CDATA[FA 0.6 Cs 0.3 MA 0.02 GA 0.08 Pb(I 0.7 Br 0.3 )3]]> 1.25 19.14 80.52 19.28 T1-4 <![CDATA[FA 0.6 Cs 0.3 GA 0.1 Pb(I 0.7 Br 0.3 )3]]> 1.27 18.26 78.32 18.19
[0138] The ratio of MABr and GABr co-doping and the performance test results of the fabricated devices are as follows: Figure 3 As shown. (a) Current density-voltage density curves of devices fabricated with different doping ratios when co-doped with MABr and GABr. The tests were conducted at room temperature under full sunlight illumination (AM1.5G, 100mW / cm²). 2 (b) The range of co-doped MABr and GABr, where the molar ratio of both MABr and GABr is 0, which represents CK1.
[0139] 1.6 Investigate the effect of different doping amounts on device performance when guanidine iodide (GAI) and methyl iodide (MAI) are co-doped in device P3.
[0140] The device performance was tested using the method described above, and the test results are shown in Table 6.
[0141] Table 6. The effect of MAI and GAI co-doping on device performance
[0142]
[0143]
[0144] Analysis of the above test results shows that introducing multi-atom alloy structures into wide bandgap solar cells, single doping with GAI or MAI, or single doping with GABr or MABr can all improve the performance of the device. However, the performance improvement is more significant when GABr or MABr is doped alone.
[0145] As shown in Tables 1 and 3, when GABr is used as a GA source for A-site doping, the device efficiency increases from 17.5% to 18.4%, while when GAI is used as a GA source for A-site doping, the device performance does not improve. The same result is observed with MABr doping; for MABr alone, the device efficiency increases from 17.5% to 19.23%, while for MAI alone, the efficiency only increases from 17.5% to 17.9% (as shown in Tables 3 and 4).
[0146] While doping with GAI or MAI, or GABr or MABr alone improves device performance, greater improvements are needed for wide-bandgap devices. Therefore, this study investigated the effect of co-doping with MABr and GABr on device performance.
[0147] From Table 5 and Figure 3 As can be seen from the table, the device performance varies depending on the ratio of MABr and GABr when co-doped. The device performance reaches its peak when both MABr and GABr are at a doping ratio of 0.05, with the efficiency increasing from 17.50% to 21.57%. Table 6 shows that co-doping with MAI and GAI improves device performance better than single-doping with MAI or GAI, but the performance improvement from co-doping is limited and not as significant as that from single-doping with MABr.
[0148] The test results above show that the doping of GA and MA has a significant effect on improving device performance. However, when using MAI and GAI doping, halide ion exchange is often introduced, which affects the lattice space and optical properties.
[0149] To further investigate the effect of MABr and GABr co-doping on device performance, the device performance was further investigated, and the results are as follows: Figures 4 to 8 As shown.
[0150] Figure 4 The images show the photoluminescence curves of the A-site alloy wide-bandgap perovskite and the conventional wide-bandgap perovskite films in Example 1. For film TF1, the corresponding perovskite is FA. 0.7 Cs 0.3 Pb(I 0.7 Br 0.3 3; For thin film TF2, x = 0.1, the corresponding perovskite is FA. 0.6 Cs 0.3 GA 0.1 Pb(I 0.7 Br 0.3 )3; For the thin film TF3, y = 0.1, the corresponding perovskite is FA. 0.6 Cs 0.3 MA0.1 Pb(I 0.7 Br 0.3 3; For the thin film TF4, x = y = 0.05, the corresponding perovskite is FA. 0.6 Cs 0.3 MA 0.05 GA 0.05 Pb(I 0.7 Br 0.3 3. These four perovskite films were prepared on cleaned ITO substrates. Photoluminescence efficiency was measured in an integrating sphere, with an excitation wavelength of 405 nm and an excitation power equivalent to that of one sun.
[0151] Figure 5 The images show time-resolved photoluminescence curves of the A-site alloy wide-bandgap perovskite film and the conventional wide-bandgap perovskite film in Example 1. Similarly, TF1, TF2, TF3, and TF4 (the same...) were used... Figure 4 Four perovskite films were prepared on cleaned ITO substrates. Time-resolved photoluminescence was measured using a fluorescence lifetime spectrometer with a standard pulse duration of 80 ps, an average power of 3 Mw, and an excitation wavelength of 450 nm.
[0152] Figure 6 This is a virtual current density-voltage density curve for the A-site alloy wide-bandgap perovskite solar cell and a conventional wide-bandgap perovskite solar cell in Example 1. The current density-voltage density curves were obtained by varying the illumination intensity.
[0153] Figure 7 The external quantum efficiency curves are those of the A-site alloy wide-bandgap perovskite solar cell and the conventional wide-bandgap perovskite solar cell in Example 1.
[0154] Figure 8 This is the long-term operational stability curve of the A-site alloy wide-bandgap perovskite solar cell in Example 1. The test was conducted at room temperature under full sunlight illumination (AM1.5G, 100mW / cm²). 2 Maximum power point tracking is performed on the packaged device.
[0155] from Figure 4 and Figure 5 As can be seen from the data, the photoluminescence intensity of the perovskite thin film is significantly improved after co-doping with MABr and GABr (e.g., Figure 4 As shown), the fluorescence lifetime was also further improved (e.g. Figure 5 As shown in the figure, this indicates that the composition of perovskite, after being doped with 0.05% MABr and 0.05% GABr, is changed from that of FA. 0.7 Cs 0.3 Pb(I 0.7 Br 0.3 )3 Regulation for FA 0.6Cs 0.3 MA 0.05 GA 0.05 Pb(I 0.7 Br 0.3 3. Defects in the perovskite film are further reduced, carrier lifetime is increased, surface nonradiative recombination is suppressed, and voltage drop of the device is reduced. The virtual voltage-current density curve of the device (e.g., Figure 6 As shown in the figure, FA 0.6 Cs 0.3 MA 0.05 GA 0.05 Pb(I 0.7 Br 0.3 )3 The fill factor loss of perovskite is less than that of FA 0.7 Cs 0.3 Pb(I 0.7 Br 0.3 )3. Perovskite. And according to the external quantum curves (as shown in Table 7 and...) Figure 7 As shown in the figure, after MA and GA regulation, FA 0.6 Cs 0.3 MA 0.05 GA 0.05 Pb(I 0.7 Br 0.3 )3 The band gap of perovskite compared to FA 0.7 Cs 0.3 Pb(I 0.7 Br 0.3 The photocurrent density was slightly improved (3), but there was no significant decrease. However, when GABr doping was used alone, the photocurrent density of the device decreased significantly. Furthermore, the operational stability of the device was significantly improved (e.g., Figure 8 (As shown).
[0156] Example 2
[0157] The fabrication of an all-perovskite tandem solar cell, and its device structure schematic diagram are shown below. Figure 9 As shown, from the light-receiving front side to the light-receiving back side, it includes, in sequence: a top electrode transparent conductive glass layer, a hole transport layer 1, a wide bandgap perovskite light-absorbing layer, an electron transport layer 1, a hole blocking layer, a tunneling composite layer, a hole transport layer 2, a narrow bandgap perovskite light-absorbing layer, an electron transport layer 2, and a metal back electrode.
[0158] The device fabrication method includes the following steps:
[0159] S1. A hole transport layer 1 is prepared on a cleaned ITO glass substrate. The hole transport layer 1 can be prepared using materials commonly used in the art. In this example, it is prepared using poly(4-phenyl)(2,4,6-trimethylphenyl)amine (PTAA) with a thickness of about 30 nm.
[0160] S2. Deposit a perovskite layer on the prepared hole transport layer 1;
[0161] The perovskite precursor solution was prepared by mixing formamidine iodide (FAI), cesium iodide (CsI), lead bromide (PbBr2), and lead iodide (PbI2) in a molar ratio of 0.7:0.3:0.45:0.55 (denoted as precursor solution S). The deposited perovskite layer is denoted as FA. 0.7 Cs 0.3 Pb(I 0.7 Br 0.3 )3 (abbreviated as FACs), with a thickness of 400nm, the all-perovskite tandem solar cell prepared by this is designated as device CK-2.
[0162] The perovskite precursor solution was prepared by mixing formamidine iodide (FAI), cesium iodide (CsI), lead bromide (PbBr2), lead iodide (PbI2), guanidine bromide (GABr), and methylammonium bromide (MABr) in a molar ratio of 0.6:0.3:0.4:0.6:0.05:0.05. The deposited perovskite layer is denoted as...
[0163] FA 0.6 Cs 0.3 MA 0.05 GA 0.05 Pb(I 0.7 Br 0.3 )3 (abbreviated as FACsMAGA, which is a wide-bandgap perovskite layer) with a thickness of 400nm, and the all-perovskite tandem solar cell prepared from it is denoted as device T4.
[0164] S3. Spin-coat a layer of piperazine monoiodide (PI) (passivation layer, corresponding to) onto the surface of the perovskite layer. Figure 9 The passivation layer in the middle has a concentration of 1 mg / mL;
[0165] S4. Preparation of a layer of fullerene (C) by thermal evaporation 60 As electron transport layer 1, its thickness is approximately 30 nm;
[0166] S5. A layer of tin oxide (SnO2) with a thickness of approximately 20 nm was prepared using atomic layer deposition as a hole blocking layer;
[0167] S6. An Au layer with a thickness of approximately 1 nm was prepared by thermal evaporation as a tunneling composite layer;
[0168] S7. Prepare a layer of polystyrene sulfonate (PEDOT:PSS) of about 50 nm on Au as hole transport layer 2;
[0169] S8. Deposit a narrow-bandgap perovskite FA layer on the prepared hole transport layer 2.0.7 MA 0.3 Pb 0.5 Sn 0.5 I3 serves as the light-absorbing layer, with a thickness of approximately 800 nm.
[0170] S9. Preparation of a layer of fullerene (C) by thermal evaporation 60 As electron transport layer 2, its thickness is approximately 30 nm;
[0171] S10. A layer of 2,9-dimethyl-4,7-diphenyl-1,10-o-diazaphenanthroline (BCP) was prepared by thermal evaporation as a hole blocking layer with a thickness of approximately 5 nm;
[0172] S11. Finally, a 150nm thick Ag layer is deposited by thermal evaporation as the back electrode.
[0173] The performance of devices CK-2 and T4 was tested, and the test results are as follows: Figure 10 and Figure 11 As shown.
[0174] Figure 10 The current density-voltage density curves for devices CK-2 and T4 are shown. The tests were conducted at room temperature under full sunlight illumination (AM1.5G, 100mW / cm²). 2 (To be continued.) Figure 10 As can be seen, compared with device CK-2, device T4 has further improved voltage and fill factor, and the final photoelectric conversion efficiency has significantly increased from 22.7% to 28.9%.
[0175] Figure 11 This is the long-term operational stability curve for device T4. The test was conducted at room temperature under full sunlight illumination (AM1.5G, 100mW / cm²). 2 Maximum power point tracking was performed on the packaged device. This showed that the operational stability of device T4 was also significantly improved.
[0176] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention and are not intended to limit the scope of protection of the present invention. For those skilled in the art, other variations or modifications can be made based on the above description and ideas, and it is neither necessary nor possible to exhaustively describe all implementation methods here. Any modifications, equivalent substitutions, and improvements made within the spirit and principles of the present invention should be included within the scope of protection of the claims of the present invention.
Claims
1. A perovskite precursor solution, wherein the solutes are formamidine iodide, cesium iodide, lead bromide, and lead iodide, characterized in that, Methylammonium bromide and guanidine bromide were used to replace part of formamidine iodide, wherein the total molar amount of methylammonium bromide and guanidine bromide was in a molar ratio of 1:6 to that of formamidine iodide.
2. The perovskite precursor solution according to claim 1, characterized in that, In the perovskite precursor solution, the molar ratio of formamidine iodide, cesium iodide, lead bromide, lead iodide, methylammonium bromide, and guanidine bromide is 0.7-xy:0.3:(0.45-0.5x-0.5y):(0.55+0.5x+0.5y):x:y; where 0 < x ≤ 0.10, 0 < y ≤ 0.10, and x + y = 0.
1.
3. The perovskite precursor solution according to claim 2, characterized in that, 0.02≤x≤0.08, 0.02≤y≤0.08; Preferably, x:y is 0.02:0.08, 0.05:0.05, or 0.08:0.
02.
4. The perovskite precursor solution according to claim 1, characterized in that, The amounts of lead bromide and lead iodide are adjusted according to the amounts of methylammonium bromide and guanidine bromide to ensure that the contents of iodide ions and bromide ions in the perovskite precursor solution are the same before and after the addition of methylammonium bromide and guanidine bromide.
5. The use of the perovskite precursor solution according to any one of claims 1 to 4 in the preparation of wide-bandgap perovskite solar cells.
6. The use according to claim 5, characterized in that, The wide-bandgap perovskite solar cell has a pin structure. Preferably, the wide-bandgap perovskite solar cell comprises, in sequence: a top electrode transparent conductive glass layer, a hole transport layer, a perovskite light-absorbing layer, an electron transport layer, and a metal back electrode, wherein the perovskite light-absorbing layer is prepared from the perovskite precursor solution described in claim 1 or 2. Preferably, a passivation layer is further provided between the perovskite light-absorbing layer and the electron transport layer.
7. A wide-bandgap perovskite solar cell, characterized in that, In order, they include: The perovskite light-absorbing layer comprises a transparent conductive glass layer, a hole transport layer, a perovskite light-absorbing layer, an electron transport layer, and a metal electrode, wherein the perovskite light-absorbing layer is prepared from the perovskite precursor solution according to any one of claims 1 to 4. Preferably, a passivation layer is further provided between the perovskite light-absorbing layer and the electron transport layer.
8. The use of the perovskite precursor solution according to any one of claims 1 to 4 in the preparation of all-perovskite tandem solar cells.
9. The use according to claim 8, characterized in that, The all-perovskite tandem solar cell comprises, in sequence: a transparent conductive glass layer, a hole transport layer 1, a wide-bandgap perovskite light-absorbing layer, an electron transport layer 1, a tunneling composite layer, a narrow-bandgap perovskite layer, an electron transport layer 2, and a metal electrode; wherein the wide-bandgap perovskite light-absorbing layer is prepared from the perovskite precursor solution described in any one of claims 1 to 4. Preferably, a passivation layer is further provided between the wide-bandgap perovskite light-absorbing layer and the electron transport layer 1; Preferably, a passivation layer is provided between the narrow bandgap perovskite layer and the electron transport layer 2.
10. A fully perovskite tandem solar cell, characterized in that, In order, they include: The perovskite has a transparent conductive glass layer, a hole transport layer 1, a wide bandgap perovskite light-absorbing layer, an electron transport layer 1, a tunneling composite layer, a hole transport layer 2, a narrow bandgap perovskite layer, an electron transport layer 2, and a metal electrode; wherein the wide bandgap perovskite light-absorbing layer is prepared from the perovskite precursor solution described in any one of claims 1 to 4.
